Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Spin-Off Invesco ETF
(NY:
CSD
)
69.34
-0.36 (-0.52%)
Official Closing Price
Updated: 8:00 PM EDT, Jul 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about S&P Spin-Off Invesco ETF
GXO Logistics Deploys Robotics Solution For Sporting Goods Retailer In France
May 14, 2024
GXO Logistics implements robotics solution for a global sporting goods retailer in France, streamlining order processing and enhancing adaptability in logistics.
Via
Benzinga
Tap Into Trends: 3 Thematic ETFs to Capture the Market’s Pulse
May 13, 2024
Invest smarter with Wall Street's exchange-traded funds and seize market momentum with these thematic ETFs to buy.
Via
InvestorPlace
Topics
ETFs
Why Carrier Global Shares Are Surging Today
April 25, 2024
Carrier Global shares are trading higher on Q1 FY24 results, with net sales and adjusted EPS beating consensus. Company also revises sales outlook and expects to resume share repurchases in 2024.
Via
Benzinga
Why Apartment Income REIT Shares Are Rocketing Today
April 08, 2024
Blackstone is acquiring Apartment Income REIT Corp. for $10 billion. The deal will take AIR Communities private and suspend dividends.
Via
Benzinga
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
August 25, 2023
RayzeBio Inc, a San Diego company focused on radiopharmaceutical therapies for cancer, filed on Thursday to raise up to $1
Via
Benzinga
Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
August 22, 2023
Waystar Inc, a provider of financial management software for hospitals and medical practices, is reportedly making strides toward an initial public offering (IPO) that could value the company up to $8...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
June 26, 2023
On Friday, Sagimet Biosciences, a clinical-stage biopharmaceutical company, filed with the SEC to raise up to $75 million in an initial public off
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.